Skip to main content

ADVERTISEMENT

Non-Malignant Blood Disorders

Julie Kanter, MD, Talks QoL Outcomes After Lentiglobin Gene Therapy for Sickle Cell Disease
Videos
12/15/2020
Dr Kanter discusses lentiglobin gene therapy for sickle cell disease, QoL data from ASH 2020, and how measuring outcomes for these patients can be improved.
Dr Kanter discusses lentiglobin gene therapy for sickle cell disease, QoL data from ASH 2020, and how measuring outcomes for these patients can be improved.
Dr Kanter discusses lentiglobin...
12/15/2020
Oncology